HAP Trading’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-24,800
Closed -$5K 1316
2022
Q4
$5K Buy
24,800
+8,900
+56% +$97.7K ﹤0.01% 1235
2022
Q3
$5K Sell
15,900
-7,000
-31% -$109K ﹤0.01% 1437
2022
Q2
$9K Buy
22,900
+4,900
+27% +$65.7K ﹤0.01% 1496
2022
Q1
$21K Sell
18,000
-7,100
-28% -$132K ﹤0.01% 1537
2021
Q4
$20K Sell
25,100
-6,100
-20% -$210K ﹤0.01% 1801
2021
Q3
$87K Sell
31,200
-28,200
-47% -$1.55M ﹤0.01% 1298
2021
Q2
$768K Sell
59,400
-12,500
-17% -$462K 0.02% 526
2021
Q1
$112K Buy
71,900
+40,700
+130% +$2.32M 0.01% 913
2020
Q4
$808K Buy
+31,200
New +$1.28M 0.02% 478
2020
Q3
Sell
-188,600
Closed -$136K 1650
2020
Q2
$136K Buy
188,600
+161,900
+606% +$4.23M 0.01% 787
2020
Q1
$32K Buy
26,700
+1,000
+4% +$25.2K ﹤0.01% 850
2019
Q4
$68K Buy
+25,700
New +$642K ﹤0.01% 648
2019
Q2
Sell
-10,500
Closed -$25K 1171
2019
Q1
$25K Buy
+10,500
New +$238K ﹤0.01% 789

Other funds holding EDIT

HAP Trading's EDIT Position: Q2 2022 in Review

HAP Trading sold out of Editas Medicine (EDIT) in Q2 2022, closing a stake of 36,831 shares — an estimated $494K sold.

HAP Trading first reported a position in EDIT in Q1 2019 and held it in 9 quarters. The position peaked at $1.16M in Q3 2021. 256 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • HAP Trading reported no remaining Editas Medicine position as of Q2 2022 after selling out during the quarter.
  • HAP Trading sold 36,831 Editas Medicine shares in Q2 2022, an estimated $494K.
  • HAP Trading first reported a position in Editas Medicine in Q1 2019 and held it in 9 quarters.
  • HAP Trading's Editas Medicine position peaked at $1.16M in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.